Literature DB >> 7901213

Evidence for a catalytic role of glutamic acid 129 in the NAD-glycohydrolase activity of the pertussis toxin S1 subunit.

R Antoine1, A Tallett, S van Heyningen, C Locht.   

Abstract

The S1 subunit of pertussis toxin is an ADP-ribosyl-transferase capable of transferring the ADP-ribose moiety of NAD+ to nucleotide-binding signal-transducing proteins of the Gi/G(o) family. In the absence of G proteins, the enzyme also catalyzes the hydrolysis of NAD+. Glu-129 was previously shown to be critical for both enzymatic activities. In this study, site-directed mutagenesis was used to make the conservative substitution of aspartate for Glu-129. The recombinant wild type and mutant proteins were purified to near homogeneity and used for enzymatic analyses. Kinetic experiments showed that the kcat of the mutant protein was about 200 times less than that of the wild type enzyme, whereas the Km for NAD+ of the two proteins were very similar, suggesting that Glu-129 is a catalytic residue for the NAD-glycohydrolase reaction of S1. This hypothesis was confirmed by a less than 2-fold change in Kd as measured by fluorescence quenching studies, indicating that the binding of NAD+ is not affected in the mutant protein in any important way. In another experiment, the replacement of Glu-129 by cysteine resulted in a disulfide bridge between Cys-129 and Cys-41 in rS1d-E129C, suggesting that the folding of the polypeptide chain is such that the catalytic Glu-129 residue is close to the amino-terminal NAD-binding site of S1. These findings imply that Glu-129 plays a key role in catalysis of the NAD-glycohydrolase reaction, possibly by electrostatically stabilizing a cationic transition state intermediate, or by serving as a general base to deprotonate the ADP-ribosyl acceptor substrates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome.

Authors:  Abhay H Pande; David Moe; Maneesha Jamnadas; Suren A Tatulian; Ken Teter
Journal:  Biochemistry       Date:  2006-11-21       Impact factor: 3.162

2.  Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.

Authors:  P Boucher; H Sato; Y Sato; C Locht
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

3.  Structure-function analyses of a pertussis-like toxin from pathogenic Escherichia coli reveal a distinct mechanism of inhibition of trimeric G-proteins.

Authors:  Dene R Littler; Sheng Y Ang; Danilo G Moriel; Martina Kocan; Oded Kleifeld; Matthew D Johnson; Mai T Tran; Adrienne W Paton; James C Paton; Roger J Summers; Mark A Schembri; Jamie Rossjohn; Travis Beddoe
Journal:  J Biol Chem       Date:  2017-06-29       Impact factor: 5.157

Review 4.  The family of bacterial ADP-ribosylating exotoxins.

Authors:  K M Krueger; J T Barbieri
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Importance of ADP-ribosylation in the morphological changes of PC12 cells induced by cholera toxin.

Authors:  C Glineur; C Locht
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.

Authors:  Salvador F Ausar; Shaolong Zhu; Jessica Duprez; Michael Cohen; Thomas Bertrand; Valérie Steier; Derek J Wilson; Stephen Li; Anthony Sheung; Roger H Brookes; Artur Pedyczak; Alexey Rak; D Andrew James
Journal:  Commun Biol       Date:  2020-08-05

Review 7.  The History of Pertussis Toxin.

Authors:  Camille Locht; Rudy Antoine
Journal:  Toxins (Basel)       Date:  2021-09-05       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.